Also, avoid low-sodium salt substitutes, as these are often made of potassium chloride
Here is the complete list of weight-related comorbidities recognized by the FDA and most insurance companies for GLP-1 eligibility
Free PCSK9 in standards, controls and samples was captured by a biotinylated monoclonal anti-human PCSK9 antibody at 100 g/mL (in-house) and detected by an Alexa-labelled PCSK9 Affinity Purified PAb antibody at 30 nM (R&D Systems) on a Gyrolab Bioaffy 1000 CD platform (Gyros AB)
MD simulations Initial wild-type GLP-1R model for MD simulations was obtained from the GLP-1R-Fab7F38 structure with modifications: (1) antibody (Fab7F38) and fusion protein (rubredoxin) were removed
Common symptoms may include nausea, digestive discomfort, bloating, fatigue, or changes in appetite
One of the concerns with GLP-1 mediated weight loss is that some of the weight lost comes from muscle rather than fat